Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients

Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients

Abstract Limited data exists on SARS-CoV-2 sustained-response to vaccine in patients with rheumatic diseases. This study aims to evaluate neutralizing antibodies (nAB) induced by SARS-CoV-2 vaccine after 3 to 6 months from administration in Systemic Lupus Erythematosus (SLE) patients, as a surrogate...

Full description

Bibliographic Details
Main Authors: Silvia Garcia-Cirera, Joan Calvet, Antoni Berenguer-Llergo, Edwards Pradenas, Silvia Marfil, Marta Massanella, Lourdes Mateu, Benjamin Trinité, Maria Llop, Marta Arévalo, Carlos Galisteo, Cristóbal Orellana, Rafael Gómez, María Nieves Gómez-Gerique, Inma Carmona, Bonaventura Clotet, Julià Blanco, Jordi Gratacós
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-18996-x

Internet

https://doi.org/10.1038/s41598-022-18996-x

Similar Items